The analysis of the long-term impact of SARS-CoV-2 on the cellular immune system in individuals recovering from COVID-19 reveals a profound NKT cell impairment

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects millions of people and killed hundred-thousands of individuals. While acute and intermediate interactions between SARS-CoV-2 and the immune system have been studied extensively, long-term impacts on the cellular immune system remained to be analyzed. Here, we comprehensively characterized immunological changes in peripheral blood mononuclear cells in 49 COVID-19 convalescent individuals (CI) in comparison to 27 matched SARS-CoV-2 unexposed individuals (UI). Despite recovery from the disease for more than 2 months, CI showed significant decreases in frequencies of invariant NKT and NKT-like cells compared to UI. Concomitant with the decrease in NKT-like cells, an increase in the percentage of Annexin V and 7-AAD double positive NKT-like cells was detected, suggesting that the reduction in NKT-like cells results from cell death months after recovery. Significant increases in regulatory T cell frequencies, TIM-3 expression on CD4 and CD8 T cells, as well as PD-L1 expression on B cells were also observed in CI, while the cytotoxic potential of T cells and NKT-like cells, defined by GzmB expression, was significantly diminished. However, both CD4 and CD8 T cells of CI showed increased Ki67 expression and were fully capable to proliferate and produce effector cytokines upon TCR stimulation. Collectively, we provide the first comprehensive characterization of immune signatures in patients recovering from SARS-CoV-2 infection, suggesting that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease.

[1]  Jiyuan Zhang,et al.  Single-cell landscape of immunological responses in COVID-19 patients , 2020, bioRxiv.

[2]  S. Huber,et al.  Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73- Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes , 2020, Cells.

[3]  A. Ganser,et al.  Reappearance of effector T cells is associated with recovery from COVID-19 , 2020, EBioMedicine.

[4]  X. Tang,et al.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.

[5]  Victor G. Puelles,et al.  Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.

[6]  M. Merad,et al.  Immunology of COVID-19: Current State of the Science , 2020, Immunity.

[7]  Carl H. June,et al.  Cytokine release syndrome in severe COVID-19 , 2020, Science.

[8]  A. Asadi-Pooya,et al.  Central nervous system manifestations of COVID-19: A systematic review , 2020, Journal of the Neurological Sciences.

[9]  Yong-tang Zheng,et al.  Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients , 2020, Cellular & Molecular Immunology.

[10]  Xiaohu Zheng,et al.  Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients , 2020, National science review.

[11]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[12]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[13]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[14]  Bo Diao,et al.  Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) , 2020, Frontiers in Immunology.

[15]  Lijuan Xiong,et al.  Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients , 2020, EBioMedicine.

[16]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[17]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[18]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[19]  M. Delorenzi,et al.  TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection , 2019, Nature.

[20]  S. Berger,et al.  TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion , 2019, Nature.

[21]  Jia Liu,et al.  Hepatitis B Virus-Specific CD8+ T Cells Maintain Functional Exhaustion after Antigen Reexposure in an Acute Activation Immune Environment , 2018, Front. Immunol..

[22]  G. Sireci,et al.  The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases , 2018, International journal of molecular sciences.

[23]  C. Chougnet,et al.  Regulatory T cells in retroviral infections , 2018, PLoS pathogens.

[24]  S. Hodge,et al.  Steroid Resistant CD8+CD28null NKT-Like Pro-inflammatory Cytotoxic Cells in Chronic Obstructive Pulmonary Disease , 2016, Front. Immunol..

[25]  B. Johnston,et al.  Regulation of NKT Cell Localization in Homeostasis and Infection , 2015, Front. Immunol..

[26]  Jia Liu,et al.  TLR1/2 Ligand–Stimulated Mouse Liver Endothelial Cells Secrete IL-12 and Trigger CD8+ T Cell Immunity In Vitro , 2013, The Journal of Immunology.

[27]  Shin-Seok Lee,et al.  Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity. , 2011, Rheumatology.

[28]  D. Godfrey,et al.  Raising the NKT cell family , 2010, Nature Immunology.

[29]  A. Gruber,et al.  The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. , 2009, Blood.

[30]  Y. Belkaid Role of Foxp3‐positive regulatory T cells during infection , 2008, European journal of immunology.

[31]  Chyung-Ru Wang,et al.  Long‐term loss of canonical NKT cells following an acute virus infection , 2005, European journal of immunology.

[32]  L. Kaer,et al.  NKT cells: what's in a name? , 2004, Nature Reviews Immunology.

[33]  P. Klenerman,et al.  Frequency and Phenotype of Circulating Vα24/Vβ11 Double-Positive Natural Killer T Cells during Hepatitis C Virus Infection , 2003, Journal of Virology.

[34]  D. Nixon,et al.  Selective Loss of Innate CD4+ Vα24 Natural Killer T Cells in Human Immunodeficiency Virus Infection , 2002, Journal of Virology.

[35]  G. Giaccone,et al.  Selective Decrease in Circulating Vα24+Vβ11+ NKT Cells During HIV Type 1 Infection1 , 2002, The Journal of Immunology.

[36]  J. A. Hobbs,et al.  Selective Loss of Natural Killer T Cells by Apoptosis following Infection with Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.

[37]  S. Hodge,et al.  Steroid resistant CD8+CD28(null) NKT-like pro-inflammatory cytotoxic cells in COPD , 2017 .

[38]  G. Giaccone,et al.  Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. , 2002, Journal of Immunology.